Liposomal borrelidin for treatment of metastatic breast cancer

Drug Delivery and Translational Research
Moonkyoung JeongJi-Ho Park

Abstract

Borrelidin is an inhibitor of threonyl-tRNA synthetase with both anticancer and antiangiogenic activities. Although borrelidin could be a potent drug that can treat metastatic cancer through synergistic therapeutic effects, its severe liver toxicity has limited the use for cancer therapeutics. In this study, we developed a liposomal formulation of borrelidin to treat metastatic breast cancer effectively through its combined anticancer and antiangiogenic effects while reducing the potential liver toxicity. The liposomal formulation was optimized to maximize loading stability and efficiency of lipophilic borrelidin in the liposomal membrane and its delivery efficiency to primary tumor in a mouse model of metastatic breast cancer. Liposomal borrelidin showed significant in vitro therapeutic effects on proliferation and migration of tumor cells and angiogenesis of endothelial cells. Furthermore, liposomal borrelidin exhibited superior inhibitory effects on primary tumor growth and lung metastasis in vivo compared to free borrelidin. More importantly, liposomal borrelidin did not induce any significant systemic toxicity in the mouse model after multiple injections.

References

Jan 1, 1981·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·J Douros, M Suffness
May 14, 2003·Applied Microbiology and Biotechnology·S KimS Y Choi
Mar 2, 2005·Nature Reviews. Cancer·Mauro Ferrari
Nov 18, 2005·Methods : a Companion to Methods in Enzymology·Aline ValsterMarc Symons
Mar 1, 2007·Vascular Health and Risk Management·Naoyo NishidaMasamichi Kojiro
Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
Sep 2, 2008·Nature Reviews. Drug Discovery·Mark E DavisDong M Shin
Jun 11, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Daniel ZuckerAmiram Goldblum
Oct 20, 2009·Trends in Pharmacological Sciences·Yogeshkumar MalamAlexander M Seifalian
Feb 2, 2010·Pediatric Research·Noah Federman, Christopher T Denny
Feb 8, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhong-Gao GaoYou Han Bae
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 26, 2011·Science·Christine L Chaffer, Robert A Weinberg
Mar 16, 2013·British Journal of Pharmacology·I G AzcárateJ M Bautista
Sep 21, 2013·Proceedings of the National Academy of Sciences of the United States of America·Amy WuJames C Sturm
Jun 26, 2014·Journal of Visualized Experiments : JoVE·Calvin R JustusLi V Yang
Dec 17, 2014·Neoplasia : an International Journal for Oncology Research·Giovanna Ferrari-AmorottiBruno Calabretta
Sep 9, 2015·Nature Biotechnology·Elvin BlancoMauro Ferrari
Mar 15, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Masoumeh ZahmatkeshanMahmoud Reza Jaafari
Mar 25, 2016·Nature Reviews. Cancer·Patricia S Steeg
Mar 28, 2017·Pharmaceutics·Upendra BulbakeWahid Khan
Jan 13, 2018·Experimental & Molecular Medicine·Seung Jae JeongSunghoon Kim

❮ Previous
Next ❯

Citations

May 11, 2019·Experimental Cell Research·Daniel W ColeAndrew M Fribley

❮ Previous
Next ❯

Methods Mentioned

BETA
Dynamic Light Scattering
optical microscopy
fluorescence imaging
fluorescence microscopy

Software Mentioned

Image J

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.